Navigation Links
Johnson Electric Launches Medication Dosing Systems
Date:3/22/2013

HONG KONG, March 22, 2013 /PRNewswire/ -- Johnson Electric today announced a miniature medication dosing system technology under the Johnson Medtech brand.  The subsystem platform provides a high precision dosing accuracy over device operational life.  The Johnson Medtech system design delivers dosing forces up to 100N for various medication viscosities within a compact package.  The low noise and low power consumption of the dosing system is suitable for the smallest portable medication delivery devices.

(Logo: http://photos.prnewswire.com/prnh/20130221/NE64514LOGO )

This innovative design includes a precise leadscrew driven by a miniature geared motor, a displacement sensor, an optical sensor and an optional force sensor.  The multiple sensors system design can prevent inaccurate dosing and supports fail-safe features for dosing.

"Accuracy is critical in medication dosing for patients with diabetes or growth hormone deficiency," said Jim Dick , Johnson Electric's senior vice president of Strategic Marketing.  "The Johnson Medtech technology enables precision dosing in miniature packages," he added.

For further information, please visit: www.johnsonelectric.com or e-mail sales@johnsonelectric.com

About Johnson Electric Group 
The Johnson Electric Group is the world's leading provider of innovative motion systems and components for automotive applications, domestic equipment, office equipment, industrial products, consumer products and medical devices.  The Group is headquartered in Hong Kong
'/>"/>

SOURCE Johnson Electric
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Johnson & Johnson to Host Analyst Conference Call on First-Quarter Results
2. Johnson & Johnson gibt Eröffnung des Innovationszentrums in London bekannt
3. Johnson & Johnson Announces Opening of London Innovation Centre
4. Kevin Johnson Joins United Allergy Services Board Of Directors
5. Free Research Report on Delta Air Lines, Inc., Johnson & Johnson, Barrick Gold Corp., Exelon Corp. and Cirrus Logic, Inc.
6. Huntington Memorial Hospital Elects Paul Johnson, Deborah Williams to its Board of Directors
7. Johnson & Johnson Presents Growth Strategies for Medical Devices & Diagnostics Segment
8. Alliqua Names David Johnson Executive Chairman of Aquamed Technologies and Member of Alliqua Board of Directors
9. Janssen and Johnson & Johnson to Provide Webcast Presentation of Immunology Pivotal Phase 3 Data Being Presented at the American College of Rheumatology Annual Meeting
10. Johnson & Johnson Postpones Medical Devices & Diagnostics Review
11. Johnson & Johnson to Host Medical Devices & Diagnostics Review
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 2014 BreedIT Corp (OTC: BRDT), ... distributor of highly sophisticated agro-breeding solutions for plant breeders ... the Company,s board of directors appointed chemistry and pharmaceutical ... new member of the board. From 1975 ... Pharmaceutical Industries Ltd (NYSE: TEVA ) and ...
(Date:1/15/2014)... -- Tegra Medical is very pleased to announce the ... its new Chief Executive Officer.  Mark was promoted from ... he has overseen the company,s four facilities in ... and Costa Rica.  Mr. King joined Tegra Medical in ... and manufacturing experience in medical device businesses, both in ...
(Date:1/15/2014)... 2014 The Cadence Fitness & Health ... Center by the Medical Fitness Association, a non-profit ... to achieve their full potential. The Cadence Fitness ... center in the western suburbs and second in ... the Cadence Fitness & Health Center meets guidelines ...
Breaking Medicine Technology:BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 2BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 3Tegra Medical Appoints New Chief Executive Officer 2Tegra Medical Appoints New Chief Executive Officer 3Cadence Fitness & Health Center Certified as Medical Fitness Facility 2Cadence Fitness & Health Center Certified as Medical Fitness Facility 3
... Cochlear, the global leader in implantable hearing ... Clark Cochlear Scholarship. Presented by Cochlear Americas, the Graeme ... seniors who,ve demonstrated exceptional achievements both in the classroom ... implant and will receive financial assistance toward their chosen ...
... PHILADELPHIA , May 4 ... SHPGY ), the global specialty biopharmaceutical company, today announced ... a change to the prescribing information for its once-daily ... ® (lisdexamfetamine dimesylate) Capsules CII, to include supplemental ...
Cached Medicine Technology:Cochlear Americas Honors Achievements of Cochlear Implant Recipients during May's Better Hearing & Speech Month 2Cochlear Americas Honors Achievements of Cochlear Implant Recipients during May's Better Hearing & Speech Month 3Cochlear Americas Honors Achievements of Cochlear Implant Recipients during May's Better Hearing & Speech Month 4FDA Approves Labeling Change for Vyvanse(R) (lisdexamfetamine dimesylate) Capsules CII to Include Supplemental Data Demonstrating Significant Efficacy at Two Hours Through 14 Hours After Administration in Adults with ADHD 2FDA Approves Labeling Change for Vyvanse(R) (lisdexamfetamine dimesylate) Capsules CII to Include Supplemental Data Demonstrating Significant Efficacy at Two Hours Through 14 Hours After Administration in Adults with ADHD 3FDA Approves Labeling Change for Vyvanse(R) (lisdexamfetamine dimesylate) Capsules CII to Include Supplemental Data Demonstrating Significant Efficacy at Two Hours Through 14 Hours After Administration in Adults with ADHD 4FDA Approves Labeling Change for Vyvanse(R) (lisdexamfetamine dimesylate) Capsules CII to Include Supplemental Data Demonstrating Significant Efficacy at Two Hours Through 14 Hours After Administration in Adults with ADHD 5FDA Approves Labeling Change for Vyvanse(R) (lisdexamfetamine dimesylate) Capsules CII to Include Supplemental Data Demonstrating Significant Efficacy at Two Hours Through 14 Hours After Administration in Adults with ADHD 6FDA Approves Labeling Change for Vyvanse(R) (lisdexamfetamine dimesylate) Capsules CII to Include Supplemental Data Demonstrating Significant Efficacy at Two Hours Through 14 Hours After Administration in Adults with ADHD 7FDA Approves Labeling Change for Vyvanse(R) (lisdexamfetamine dimesylate) Capsules CII to Include Supplemental Data Demonstrating Significant Efficacy at Two Hours Through 14 Hours After Administration in Adults with ADHD 8
(Date:4/14/2014)... orphaned by HIV/AIDS in South Africa may provide insight ... behavior issues in other areas of the world, which ... that could lead to successful interventions. , A ... United Nations mentions that due to the HIV/AIDS pandemic, ... African, children are at an increased risk for mental ...
(Date:4/14/2014)... A new study shows that moderate to severe ... risk of stroke, cancer and death. , Results of ... to severe obstructive sleep apnea were four times more ... times more likely to have a stroke (HR = ... (HR = 3.4), and 2.5 times more likely to ...
(Date:4/14/2014)... Dallas study involving serious youth offenders, the answer to one ... seven years: "How long do you think you,ll live?", According ... offending over time., Author Dr. Alex Piquero said the study ... of them offend at very high rates and commit more ... much later in life offend much less., "In a lot ...
(Date:4/14/2014)... with symptoms increasing dramatically during some of the most important ... has found. , Depressive symptoms increased on average by 68 ... young men, who were around 25 years old when they ... their children. The results of the study were published April ... is the first to identify when young fathers are at ...
(Date:4/14/2014)... Lower weight babies and babies who aren,t breastfed ... risk of developing chronic inflammation and related health ... study. , "There were good reasons to hypothesize ... inflammation in adulthood," says Thomas McDade (Northwestern University), ... in the Child & Brain Development program. "It ...
Breaking Medicine News(10 mins):Health News:Researchers identify children with emotional behavior difficulties 2Health News:Researchers identify children with emotional behavior difficulties 3Health News:Study links severe sleep apnea to increased risk of stroke, cancer and death 2Health News:UT Dallas study: Youth who fail to envision future commit more crimes 2Health News:Young dads at high risk of depression, too 2Health News:Low birth weight, less breastfeeding create later health risks 2
... Feb. 27 Novartis and Sony Pictures Television,International,s ... a breast cancer prevention and early detection campaign ... combines,Novartis, resources and expertise in oncology and SPTI,s ... their fight against breast cancer.,The campaign is called ...
... Feb. 27 Today, the U.S. House,Foreign Affairs ... the U.S. Global Leadership Against HIV/AIDS, Tuberculosis, and,Malaria ... Family Research Council, released the,following statement:, "I ... an HIV/AIDS,bill free of troubling provisions contained in ...
... The UCLA Department of Family Medicine, with support from the ... Research on Health and Healthcare, a group that will study ... , The network will also mentor and develop a ... disparities. , The new group to ...
... can show injury in as little as 6 days ... sclerosis drug Tysabri can start causing liver damage within six ... , In January, the U.S. Food and Drug Administration expanded ... inflammation of the digestive tract. , The drug has also ...
... Wellesse announces the launch,of its first-ever online sweepstakes, ... enter for a chance to win a year,s ... at, http://www.wellesse.com . The sweepstakes launched February 14, ... newest online campaign is part of our overall ...
... Acura,Pharmaceuticals, Inc. (Nasdaq: ACUR ) announced that ... leave of absence for health,reasons for an as-yet undetermined ... of the Company,s Board of Directors. At the same ... to serve as,non-executive Chairman of the Board. Mr. Markham ...
Cached Medicine News:Health News:Novartis and Sony Pictures Television International's Latin American Advertising Sales Group Launch Partnership to Create Multi-Media Platform for Breast Cancer Awareness, Detection, and Treatment in Latin America 2Health News:Novartis and Sony Pictures Television International's Latin American Advertising Sales Group Launch Partnership to Create Multi-Media Platform for Breast Cancer Awareness, Detection, and Treatment in Latin America 3Health News:Novartis and Sony Pictures Television International's Latin American Advertising Sales Group Launch Partnership to Create Multi-Media Platform for Breast Cancer Awareness, Detection, and Treatment in Latin America 4Health News:UCLA launches network to study health care disparities affecting minorities 2Health News:Tysabri May Cause Liver Damage, Health Officials Say 2Health News:WELLESSE(TM) Announces the 'Keep Your Body in Motion' Sweepstakes 2Health News:Acura Pharmaceuticals, Inc. Announces Andrew Reddick, President & CEO, To Take Medical Leave and Appointment of Richard Markham as Chairman of the Board 2Health News:Acura Pharmaceuticals, Inc. Announces Andrew Reddick, President & CEO, To Take Medical Leave and Appointment of Richard Markham as Chairman of the Board 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: